These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 36576348)

  • 1. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear biomarkers in dry eye disease: Progress in the last decade.
    Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of dry eye disease and novel therapeutic targets.
    Messmer EM
    Exp Eye Res; 2022 Apr; 217():108944. PubMed ID: 35077753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief.
    Shahraki T; Baradaran-Rafii A; Ayyala R; Arabi A; Jarstad J; Memar F
    Int Ophthalmol; 2024 Feb; 44(1):49. PubMed ID: 38337030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intricate insights into immune response in dry eye disease.
    Kaur RP; Gurnani B; Kaur K
    Indian J Ophthalmol; 2023 Apr; 71(4):1248-1255. PubMed ID: 37026255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
    Sheppard JD; Nichols KK
    Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.
    Donthineni PR; Doctor MB; Shanbhag S; Kate A; Galor A; Djalilian AR; Singh S; Basu S
    Indian J Ophthalmol; 2023 Apr; 71(4):1332-1347. PubMed ID: 37026265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in pharmaceutical treatment of dry eye disease: A review.
    Mohamed HB; Abd El-Hamid BN; Fathalla D; Fouad EA
    Eur J Pharm Sci; 2022 Aug; 175():106206. PubMed ID: 35568107
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.